home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Revolution Medicines Announces Pricing of $156.0 Million Public Offering of Common Stock
Revolution Medicines Announces Pricing of $156.0 Million Public Offering of Common Stock
Post navigation
Previous Post
Previous
Kinnate Biopharma Appoints Dr. Richard Williams as Chief Medical Officer
Next Post
Next
Kronos Bio Reports Positive Results of Preclinical Study of KB-0742, an Investigational CDK9 Inhibitor, Demonstrating Potency, Selectivity and Anti-tumor Activity in Prostate Cancer Model